Success Metrics

Clinical Success Rate

85.7%

Based on 6 completed trials

Completion Rate

86%(6/7)

Active Trials

3(21%)

Results Posted

50%(3 trials)

Terminated

1(7%)

Phase Distribution

Ph early_phase_1

21%

Ph not_applicable

50%

Ph phase_3

Ph phase_2

21%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution14 total trials

Early Phase 1First-in-human

3(21.4%)

Phase 2Efficacy & side effects

3(21.4%)

Phase 3Large-scale testing

1(7.1%)

N/ANon-phased studies

7(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(5)

Completed(6)

Terminated(2)

Other(1)

Detailed Status

Completed6

Recruiting3

Not yet recruiting2

Withdrawn1

unknown1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

85.7%

Most Advanced

Phase 3

Trials by Phase

Early Phase 13 (21.4%)

Phase 23 (21.4%)

Phase 31 (7.1%)

N/A7 (50.0%)

Trials by Status

withdrawn17%

recruiting321%

unknown17%

completed643%

terminated17%

not_yet_recruiting214%

Recent Activity

3 active trials

Showing 5 of 14

not_yet_recruitingphase_3

A Phase 3 Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After Acute Ischemic Stroke

NCT07645586

not_yet_recruitingphase_2

A Phase 2b Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After Acute Ischemic Stroke

NCT07645560

withdrawnearly_phase_1

Clinical Trials (14)

Showing 14 of 14 trials

NCT07645586Phase 3

A Phase 3 Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After Acute Ischemic Stroke

Not Yet Recruiting

NCT07645560Phase 2

A Phase 2b Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After Acute Ischemic Stroke

Not Yet Recruiting

NCT06695637Early Phase 1

Individualized Neuromodulation of Craving Control for Meth Use Disorders

Withdrawn

NCT06265766Not Applicable

Brain STimulation for Arm Recovery After Stroke 2

Recruiting

NCT06060496Not Applicable

Theta Burst Stimulation for Alcohol Use Disorder

Completed

NCT05842304Not Applicable

Individualized Precision rTMS for Language Recovery in Patients After Ischemic Stroke: a Multi-center RCT

Recruiting

NCT04953559Not Applicable

Transcranial Magnetic Stimulation of the Default Mode Network to Improve Sleep

Recruiting

NCT03576768Not Applicable

QuitFast: Evaluating Transcranial Magnetic Stimulation as a Tool to Reduce Smoking Directly Following a Quit Attempt

Terminated

NCT03148470Not Applicable

Impact of Theta Burst Stimulation Over the Left DLPFC on Language Switching

Completed

NCT03238859Phase 2

10 Days of Theta Burst Stimulation as a Tool to Treat Cocaine Dependence

Completed

NCT03576781Early Phase 1

Developing rTMS Treatment Strategies for Pain in Opiate Dependence

Completed

NCT03579953Early Phase 1

Nicotine TMS EFT Smoking Pilot Study

Completed

NCT03603561Not Applicable

Continuous Theta Burst Stimulation as an add-on Treatment for Bipolar Depression

Unknown

NCT01478880Phase 2

Efficacy and Safety of Bilateral Theta Burst Stimulation for the Treatment of Auditory Hallucinations

Completed

All 14 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 14